EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nonhormonal management of endometriosis: Role of dopamine D2 receptor agonists in preserving fertility and ovarian function

Rahi Tinni Basu, Pradip Kumar Mitra

F&S Reports · 2026-10 · 7 (5) · 357-361

DOI: 10.1016/j.xfre.2026.07.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift F&S Reports, 2026-10. Verfasst von Rahi Tinni Basu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ohio State University, Columbus, Ohio. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dopamine D2 receptor (DRD2) agonists represent a promising targeted, nonhormonal therapeutic strategy for endometriosis. These agents selectively downregulate vascular endothelial growth factor-A signaling, thereby inhibiting the aberrant angiogenesis that supports the survival and proliferation of endometriotic lesions. This review synthesizes preclinical and early clinical evidence on DRD2 targeting, with a focus on the clinical translation of cabergoline and quinagolide. In a randomized, double-blind, placebo-controlled pilot trial, a 6-month cabergoline regimen significantly reduced chronic pelvic pain scores and improved pain relief without serious adverse events. Additionally, post hoc analysis of lesion regression showed that 61.3% of lesions in the quinagolide group demonstrated regression, while ovulatory function was preserved in 93% of participants, consistent with maintenance of the hypothalamic-pituitary-ovarian axis. Collectively, these data suggest that DRD2 agonists may represent a fertility-compatible, mechanistically targeted therapeutic approach and underscore the need for adequately powered phase 3 clinical trials.

Schlagwörter

Stichwörter der Autor:innen

Dopamine D2 receptor (DRD2) agonistsendometriosisfertilityvascular endothelial growth factor-A (VEGF-A)

Autor:innen und Institutionen

  • Ohio State University, Columbus, Ohio.
  • Endometriosis Society India, Kolkata, India.

Zitieren

APA

Basu, R. T., & Mitra, P. K. (2026). Nonhormonal management of endometriosis: Role of dopamine D2 receptor agonists in preserving fertility and ovarian function. F&S Reports, 7(5), 357-361. https://doi.org/10.1016/j.xfre.2026.07.005

Vancouver

Basu RT, Mitra PK. Nonhormonal management of endometriosis: Role of dopamine D2 receptor agonists in preserving fertility and ovarian function. F&S Reports. 2026;7(5):357-361. doi:10.1016/j.xfre.2026.07.005

BibTeX
@article{Basu2026,
  author = {Basu, Rahi Tinni and Mitra, Pradip Kumar},
  title = {Nonhormonal management of endometriosis: Role of dopamine D2 receptor agonists in preserving fertility and ovarian function},
  journal = {F&S Reports},
  year = {2026},
  volume = {7},
  number = {5},
  pages = {357--361},
  doi = {10.1016/j.xfre.2026.07.005}
}
Kostenlos starten →